Evidence map›Paper›PMID 26272935›Full record

ArticleThe Journal of infectious diseases2016

Human Neutrophils Are Primed by Chemoattractant Gradients for Blocking the Growth of Aspergillus fumigatus.

Caroline N Jones, Laurie Dimisko, Kevin Forrest, Kevin Judice, Mark C Poznansky, James F Markmann, Jatin M Vyas, Daniel Irimia

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of infectious diseases, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
2.5field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 33 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Neutrophil attachment via Mac-1 (Philosophical transactions of the Royal Society of London. Series B, Biological sciences · 2023
    Article
  5. Review
  6. Review
  7. Neutrophil dysfunction in cystic fibrosis.Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society · 2021
    Article
  8. Immune Cell Paracrine Signaling Drives the Neutrophil Response toCellular and molecular bioengineering · 2021
    Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. Article
  14. It takes a village: Phagocytes play a central role in fungal immunity.Seminars in cell & developmental biology · 2019
    Review
  15. Article
  16. Article
  17. Review
  18. Article
  19. Multikingdom microscale models.PLoS pathogens · 2017
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 2 countries.

Caroline N JonesBioMEMS Resource Center Department of Surgery.
Laurie DimiskoBioMEMS Resource Center Department of Surgery.
Kevin ForrestCidara Therapeutics, San Diego, California.
Kevin JudiceCidara Therapeutics, San Diego, California.
Mark C PoznanskyVaccine and Immunotherapy Center Division of Infectious Diseases, Massachusetts General Hospital and Harvard Medical School, Boston.
James F MarkmannDivision of Transplantation Department of Surgery.
Jatin M VyasDivision of Infectious Diseases, Massachusetts General Hospital and Harvard Medical School, Boston.
Daniel IrimiaBioMEMS Resource Center Department of Surgery.
Cidara Therapeutics (United States) · USHarvard University · USMassachusetts General Hospital · USNHS Blood and Transplant · GB

Funding

Bio-MicroElectroMechanical Systems Resource CenterP41EB002503 · NIBIB · MASSACHUSETTS GENERAL HOSPITAL · PI TONER, MEHMET · 2004 to 2018
$17.4M
Neutrophil Decision Making in Confined Environments in Health and DiseaseR01GM092804 · NIGMS · MASSACHUSETTS GENERAL HOSPITAL · PI IRIMIA, DANIEL · 2010 to 2022
$4.3M
Functional Role of the Tetraspanin CD82/Kai1 in Innate and Adaptive ImmunityR01AI092084 · NIAID · MASSACHUSETTS GENERAL HOSPITAL · PI VYAS, JATIN M · 2011 to 2015
$2.2M
The role of TLR9 on Aspergillus fumigatus phagosomesR01AI097519 · NIAID · MASSACHUSETTS GENERAL HOSPITAL · PI VYAS, JATIN M · 2013 to 2016
$1.6M
NIAID NIH HHS R01 AI092084NIAID NIH HHS R01 AI097519NIBIB NIH HHS EB002503NIBIB NIH HHS P41 EB002503NIGMS NIH HHS GM092804NIGMS NIH HHS R01 GM092804
6 · The paper itself

Abstract

The contribution of human neutrophils to the protection against fungal infections by Aspergillus fumigatus is essential but not fully understood. Whereas healthy people can inhale spores of A. fumigatus without developing disease, neutropenic patients and those receiving immunosuppressive drugs have a higher incidence of invasive fungal infections. To study the role of neutrophils in protection against A. fumigatus infections, we developed an in vitro assay in which the interactions between human neutrophils and A. fumigatus were observed in real time, at single-cell resolution, in precisely controlled conditions. We measured the outcomes of neutrophil-fungus interactions and found that human neutrophils have a limited ability to migrate toward A. fumigatus and block the growth of A. fumigatus conidia (proportion with growth blocked, 69%). The blocking ability of human neutrophils increased to 85.1% when they were stimulated by uniform concentrations of fMLP and was enhanced further, to 99.4%, in the presence of chemoattractant gradients. Neutrophils from patients receiving immunosuppressive treatment after transplantation were less effective against the fungus than those from healthy donors, and broader heterogeneity exists between patients, compared with healthy individuals. Further studies using this microfluidic platform will help understand the relevance of innate immune deficiencies responsible for the higher risk of fungal infections in patients with immunosuppressive disease.

Indexed as

AdolescentAdultAspergillus fumigatusChemotactic FactorsHumansInterleukin-1Lab-On-A-Chip DevicesNeutrophilsN-Formylmethionine Leucyl-PhenylalanineYoung AdultChemotactic FactorsInterleukin-1N-Formylmethionine Leucyl-PhenylalanineA. fumigatuschemoattractantshost-pathogen interactionmicrofluidicsneutrophil

Identifiers

PMID26272935
PMCPMC4704668
OpenAlexW2197454865

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.